Yes, tirzepatide lawsuits are a part of MDL 3094, pending lawsuits against glucagon-like peptide-1 receptor agonists (GLP-1 RAs) manufacturers, such as Eli Lilly and Novo Nordisk.
The plaintiffs claim that the manufacturers failed to warn them about severe health conditions that can stem from the medications, like gastroparesis, vision loss, ileus, bowel obstruction, and persistent vomiting.
You can check your eligibility for a tirzepatide claim with a case evaluation from our experts at Atraxia Law. To get started, prepare your medical records that prove you’ve been diagnosed with gastroparesis, vision loss, and bowel obstruction as a result of using Mounjaro and Zepbound. If you qualify, we will put you in touch with a tirzepatide lawyer who will file the claim on your behalf.